Publications

Supplementary Data from Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Authors: F Hesse, AJ Wright, V Somai, F Bulat, F Kreis, KM Brindle

E-pub date: 31 Mar 2023

Journal name:

Supplementary Data from Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Authors: F Hesse, AJ Wright, V Somai, F Bulat, F Kreis, KM Brindle

E-pub date: 31 Mar 2023

Journal name:

Data from Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Authors: F Hesse, AJ Wright, V Somai, F Bulat, F Kreis, KM Brindle

E-pub date: 31 Mar 2023

Journal name:

Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Authors: K Khayati, V Bhatt, T Lan, F Alogaili, W Wang, E Lopez, ZS Hu, S Gokhale, L...

E-pub date: 31 Mar 2023

Journal name:

Supplementary Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Authors: K Khayati, V Bhatt, T Lan, F Alogaili, W Wang, E Lopez, ZS Hu, S Gokhale, L...

E-pub date: 31 Mar 2023

Journal name:

Supplementary Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Authors: K Khayati, V Bhatt, T Lan, F Alogaili, W Wang, E Lopez, ZS Hu, S Gokhale, L...

E-pub date: 31 Mar 2023

Journal name:

Supplementary Data from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 31 Mar 2023

Journal name:

Supplementary Data from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Authors: I Quiros-Gonzalez, MR Tomaszewski, MA Golinska, E Brown, L Ansel-Bollepalli...

E-pub date: 31 Mar 2023

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Supplementary Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Supplementary Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Supplementary Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Supplementary Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Supplementary Data from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Supplementary Data from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Supplementary Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Supplementary Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Supplementary Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Supplementary Data from Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer

Supplementary Data from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

Supplementary Data from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models